Boys and Girls it time to have fun and do some good selling and save lots of lives. Congratulations to the MRL team. Make sure we get a good clean label. So Merck in Back!
This may not be as bad as Victrelis but isn't going to be as good as Harvoni nor its follow up coming soon. Don't get too full of yourselves. HCV has been dummied down from the good old interferon days, hell, a PCP could treat this with no more than a phone consult to a hepatologist. If you put any form of screening algorithm into the mix, you'll lose 4 out of 5 treaters. If you price it 70% of Harvoni, you may get traction via step edits initially but Gilead will counter. Enjoy your time in the sun, it will be short, not sweet..... Respectfully, A Former HCV Sales Veteran Who Kicked Your Ass with Pegasys
